NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first phase 3, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID (LC), also known as long-haul COVID or post-acute sequelae of COVID-19. The study is funded by the National Institutes of Health’s National Institute on Aging.

Timothy Blackwell to chair the Department of Internal Medicine at the University of Michigan

Timothy Blackwell, MD, Rudy W. Jacobson Professor of Pulmonary Medicine and director of the Division of Allergy, Pulmonary and Critical Care Medicine, is leaving Vanderbilt University Medical Center to chair the Department of Internal Medicine at the University of Michigan. He assumes his new role on March 1.

Study finds no difference in heart transplant outcomes using organs donated after circulatory death and after brain death

A Vanderbilt study by Cardiovascular Medicine Drs. Hasan Siddiqi, Kelly Schlendorf and colleagues found no difference in one-year survival and other outcomes among heart transplant patients who received their new organs from from donation after circulatory death and donation after brain death.